1.
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy.
Future Sci OA
; 8(3): FSO784, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35251698